UPClytics

Decisions

DateCaseDivisionActionMotionOutcomeSummary
2024-07-16CC_586764/2023Munich CDCounterclaim for revocationRevocation meritsRevokedThe patent EP 3 666 797 B1 was revoked in its entirety for all Contracting Member States in which revocation was requested. The Main Request and all 17 Auxiliary Requests were found to lack inventive step. The defendant (patent proprietor Amgen) was ordered to bear the claimant's legal costs, agreed at EUR 1.375 million.